Comparisons between novel oral anticoagulants and vitamin K antagonists in patients with CKD.
about
Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative ManagementGuidance for the practical management of warfarin therapy in the treatment of venous thromboembolismRisk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational StudiesNon-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused ReviewAdverse safety events in patients with Chronic Kidney Disease (CKD).Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort studyNon-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation.Target-specific oral anticoagulants: should we switch from warfarin?Risk Factors for Bleeding in Hospitalized at Risk Patients With an INR of 5 or More Treated With Vitamin K Antagonists.Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis.Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants.Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerationsAssessment of Direct Oral Anticoagulant Prescribing and Monitoring Pre- and Post-Implementation of a Pharmacy Protocol at a Community Teaching Hospital.Atrial fibrillation and chronic kidney disease: struggling through thick and thin.Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohort.The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study.Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation.Dosing challenges with direct oral anticoagulants in the elderly: a retrospective analysis
P2860
Q26801895-9D7D9271-AC8D-4884-A909-8AC318530F21Q28066527-C48D1E49-6AC0-4F9B-962B-5415F46861C9Q28078747-928550BB-A0C9-42A2-8F46-E3B48A044AC1Q28081918-CEFFB1F5-4908-4ACE-B5DC-17576486671DQ30245199-2B8A65AE-D55C-4BD6-9A5A-92CEED980F78Q33647367-B63AD55D-FF3D-438D-9E53-B568C0DE6D4EQ33844478-AA76C7D1-206C-4E66-B28F-99303489662CQ35758778-175CE04A-4CC1-4ABF-B966-97FD77D487F3Q37624211-726A0338-E13C-4F26-9A87-6C20B74BD8C9Q38270489-9F91819E-2E68-483A-98CB-2E9A407FA587Q38345740-3BC89A6B-FC80-43A5-9A8A-1C737F1A4F12Q38389058-DE2FDA77-42AA-419D-9CAA-1D46DF0D9059Q38707885-220D3374-F61A-4709-86B4-2CCAA5D43F81Q38821933-F68A67F8-99CE-4073-A2C6-15C4014AB092Q38981275-0D9DBBF7-A343-4A78-9DE6-CC2235C2D85FQ40142501-541ACB17-54C8-4EB2-B5B0-FE469EF68052Q41036908-6139FFBC-6294-4637-9D8F-E693F0AFFB73Q41486453-BD805D1B-CEFE-4E9E-83B5-58D1BCA92084Q47365787-6106137E-F86C-436D-9F9D-8D3E59FD0D54Q58574436-B9541CDD-93EB-41B4-9146-337C0CC009A8
P2860
Comparisons between novel oral anticoagulants and vitamin K antagonists in patients with CKD.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comparisons between novel oral ...... agonists in patients with CKD.
@ast
Comparisons between novel oral ...... agonists in patients with CKD.
@en
type
label
Comparisons between novel oral ...... agonists in patients with CKD.
@ast
Comparisons between novel oral ...... agonists in patients with CKD.
@en
prefLabel
Comparisons between novel oral ...... agonists in patients with CKD.
@ast
Comparisons between novel oral ...... agonists in patients with CKD.
@en
P2093
P2860
P356
P1476
Comparisons between novel oral ...... tagonists in patients with CKD
@en
P2093
Jeffrey Perl
Katerina Pavenski
Prakesh S Shah
Shai Harel
P2860
P304
P356
10.1681/ASN.2013040361
P577
2014-01-02T00:00:00Z